Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 2—February 2016

AP92-like Crimean-Congo Hemorrhagic Fever Virus in Hyalomma aegyptium Ticks, Algeria

Cite This Article

To the Editor: Crimean-Congo hemorrhagic fever virus (CCHFV) (Nairovirus, Bunyaviridae), the causative agent of Crimean-Congo hemorrhagic fever, has been detected in sub-Saharan Africa, southeastern Europe, the Middle East, and central Asia. The virus has been detected in >31 species of ticks and is transmitted to humans by bite of infected ticks (mainly of the genus Hyalomma) or by contact with body fluids or tissue of viremic patients or livestock. The disease is characterized by fever, myalgia, headache, vomiting, and sometimes hemorrhage; reported mortality rate is 10%–50% (1).

CCHFV strains currently constitute 7 evolutionary lineages, 1 of which (Europe 2) contains the prototype strain AP92, which was isolated in 1975 from Rhipicephalus bursa ticks collected from goats in Greece (2). This strain seems to have low or no pathogenicity for humans; only a few mild cases have been reported (3). This observation is supported by the relatively high (14.4%) seroprevalence but no clinical cases in humans in northwestern Greece (4). The documented tick carriers of this strain are R. bursa and Hyalomma marginatum (5).

Hyalomma aegyptium ticks are highly host specific; adults feed almost entirely on tortoises of the genus Testudo (6) and occassionally on hedgehogs and hares. Unlike adult ticks, the larvae and nymphs are less host specific and feed on a wide spectrum of hosts (e.g., other reptiles, birds, and mammals [including humans]) (7). This trait elevates the epidemiologic role of the tick as a possible bridge vector connecting wildlife, domestic animals, and humans.

To determine the biological and epidemiological role of H. aegyptium ticks, during 2009–2010, we collected 56 adult ticks from 12 Testudo graeca tortoises at a locality near the city of Aflou in Laghouat Province, Algeria. We tested the ticks for probable CCHFV infection by using nested reverse transcription PCR (8), which amplifies a partial fragment of the CCHFV small RNA segment. We slightly modified the assay: reverse transcription time was 60 minutes and annealing temperature was 52°C (9).


Thumbnail of Phylogenetic analysis of Crimean-Congo hemorrhagic fever virus small RNA segment sequences, performed by using Bayesian inference in MrBayes version 3.1.2. ( under a GTR + Γ + I (general time-reversible plus gamma distribution plus invariable site) model with 107 generations setup. Bootstrap values (>50%) are shown at nodes, * indicates 1.00 bootstrap value. The scale bar represents the estimated number of substitutions per site. Individual sequences

Figure. Phylogenetic analysis of Crimean-Congo hemorrhagic fever virus small RNA segment sequences, performed by using Bayesian inference in MrBayes version 3.1.2. ( under a general time-reversible plus gamma distribution plus invariable...

In total, 16 (28.6%) ticks were positive for CCHFV. The PCR products of 15 (26.8%) positive samples were sequenced. BLAST ( analysis identified all 15 sequences as CCHFV with 98%–100% identity to the AP92 strain (GenBank accession no. DQ211638). Two variants of AP92 were detected and differed by 0.6%. A phylogenetic tree was constructed by Bayesian inference, using MrBayes version 3.1.2 ( under a general time-reversible plus gamma distribution plus invariable site model with 107 generations setup (Figure). Sequences are available in GenBank (accession nos. KT99097 and KT99098).

Our findings demonstrate the presence of CCHFV in Algeria, either recently introduced or overlooked. The nearest location where CCHFV has been reported is the Zouala region in Morocco, where the virus was detected in H. marginatum tick larvae and nymphs collected from migratory birds (10). It also confirms association of AP92-like sequences with H. aegyptium ticks.

This study shows that the Europe 2 lineage is not restricted to the Balkan region and Turkey. The role of H. aegyptium ticks as CCHFV vectors should be further tested. Further investigation of the distribution of CCHFV in ticks in Algeria is also needed. To date, CCHFV strains of lineage Europe 2 have not been associated with severe disease in humans. However, physicians in Algeria should be aware of potential Crimean-Congo hemorrhagic fever cases.



This study was supported by the Internal Grant Agency of the University of Veterinary and Pharmaceutical Sciences Brno (project no. 15/2015/FVHE). A.P. is supported by the ANTIGONE EU project (grant no. 278976).


Matej Kautman, Ghoulem Tiar, Anna Papa, and Pavel ŠirokýComments to Author 

Author affiliations: University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic (M. Kautman, P. Široký); University Chadli Bendjedid, El Tarf, Algeria (G. Tiar); Aristotle University of Thessaloniki, Thessaloniki, Greece (A. Papa); Central European Institute of Technology, Brno (P. Široký)



  1. Whitehouse  CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:14560. DOIPubMed
  2. Papadopoulos  O, Koptopoulos  G. Crimean-Congo hemorrhagic fever (CCHFV) in Greece: isolation of the virus from Rhipicephalus bursa ticks and a preliminary serological survey. In: Vesenjak-Hirjan J, editor. Arboviruses in the Mediterranean countries. Stuttgart (Germany): Gustav Fisher Verlag; 1980. p. 117–21.
  3. Midilli  K, Gargili  A, Ergonul  O, Elevli  M, Ergin  S, Turan  N, The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a field survey. BMC Infect Dis. 2009;9:90. DOIPubMed
  4. Papa  A, Sidira  P, Kallia  S, Ntouska  M, Zotos  N, Doumbali  E, Factors associated with IgG positivity to Crimean-Congo hemorrhagic fever virus in the area with the highest seroprevalence in Greece. Ticks Tick Borne Dis. 2013;4:417–20.
  5. Gargili  A, Midilli  K, Ergonul  O, Ergin  S, Alp  HG, Vatansever  Z, Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans. Vector Borne Zoonotic Dis. 2011;11:74752. DOIPubMed
  6. Široký  P, Petrželková  KJ, Kamler  M, Mihalca  AD, Modrý  D. Hyalomma aegyptium as dominant tick in tortoises of the genus Testudo in Balkan countries, with notes on its host preferences. Exp Appl Acarol. 2006;40:27990. DOIPubMed
  7. Kar  S, Dervis  E, Akin  A, Ergonul  O, Gargili  A. Preferences of different tick species for human hosts in Turkey. Exp Appl Acarol. 2013;61:34955. DOIPubMed
  8. Schwarz  TF, Nsanze  H, Longson  M, Nitschko  H, Gilch  S, Shurie  H, Polyrmerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am J Trop Med Hyg. 1996;55:1906 .PubMed
  9. Široký  P, Bělohlávek  T, Papoušek  I, Jandzik  D, Mikulíček  P, Kubelová  M, Hidden threat of tortoise ticks: high prevalence of Crimean-Congo haemorrhagic fever virus in ticks Hyalomma aegyptium in the Middle East. Parasit Vectors. 2014;7:101.
  10. Palomar  AM, Portillo  A, Santibáñez  P, Mazuelas  D, Arizaga  J, Crespo  A, Crimean-congo hemorrhagic fever virus in ticks from migratory birds, Morocco. Emerg Infect Dis. 2013;19:2603. DOIPubMed




Cite This Article

DOI: 10.3201/eid2202.151528

Related Links


Table of Contents – Volume 22, Number 2—February 2016


Please use the form below to submit correspondence to the authors or contact them at the following address:

Pavel Široký, Department of Biology and Wildlife Diseases, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences, Palackého tř. 1/3, 612 42 Brno, Czech Republic

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.


Page created: January 19, 2016
Page updated: January 19, 2016
Page reviewed: January 19, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.